Advertisement

Topics

Risk of Meningioma with Cyproterone: EMA Review Begins

08:57 EDT 12 Jul 2019 | Medscape

Products containing the anti-androgens cyproterone and cyproterone acetate — widely used in European countries — have been associated with a risk of meningioma.
News Alerts

Original Article: Risk of Meningioma with Cyproterone: EMA Review Begins

NEXT ARTICLE

More From BioPortfolio on "Risk of Meningioma with Cyproterone: EMA Review Begins"

Advertisement
Quick Search
Advertisement
Advertisement